[ad_1]
Dr Anthony Fauci warned on Wednesday that the COVID-19 vaccination does not give people a ‘free pass to travel’ as health officials announced the full vaccination of just 3.8 million Americans and hundreds have been seen lining up to receive the vaccine at Dodger Stadium in hard-hit California.
The nation’s top infectious disease expert appeared at a CNN Global town hall hosted by Anderson Cooper and Dr Sanjay Gupta when he answered a viewer’s question about when immunity began after receiving the vaccine.
Retired nurse Carole Gardner told Fauci that she and her husband were unable to travel to see their grandchildren. She explained that she and her husband will receive the second dose of the Moderna vaccine on February 19.
“When will we have immunity and when can we travel?” Gardner asks.
In response, Fauci said, “Peak immunity starts around 10 days to two weeks and beyond after the second dose … That would give you around 94-95% efficacy and a good safety profile.”
However, Fauci warned that it is “not a good idea to travel, period.”
Dr Anthony Fauci warned on Wednesday that the COVID-19 vaccine does not give people a ‘free pass to travel’
Motorists were still lined up for vaccinations and COVID-19 testing in the parking lot at Dodger Stadium in Los Angeles on Wednesday night.
“We don’t want people to think, because they’ve been vaccinated, that other public health recommendations just don’t apply,” he continued.
“So getting the vaccine doesn’t mean that I now have a free pass to travel, nor that I have a free pass to put aside all the public health measures we talk about all the time,” Fauci said.
Meanwhile, hundreds of motorists were seen lining up to be vaccinated at the hard-hit Dodger Stadium in Los Angeles Wednesday night. More than a million cases have been reported in Los Angeles County and at least 15,897 people have died.
His remarks came just a day after Johnson and Johnson announced that he would likely release the results of phase three trials of his coronavirus vaccine in one shot next week.
Its vaccine is cheaper and easier to store and transport, which, together with the fact that it only requires a single dose, could help accelerate the extremely slow deployment of the vaccine in the United States.
The 100 million doses Johnson & Johnson promised the United States would increase the U.S. supply by about 25 percent.
President Joe Biden’s COVID-19 response team has admitted, however, that it will be months before anyone who wants a vaccine can get one, and that “ we will run into unforeseen problems, ” he said. Interim Administrator of the Centers for Medicare and Medicaid Services Andy Slavitt.
Earlier Wednesday, drivers were seen lining up at the COVID-19 mega vaccination site that was set up in the parking lot at Dodger Stadium
Vaccinations began five weeks ago, but only 6.2% of the American population received their first doses of two-dose vaccines from Pfizer or Moderna. This comes down to about 20.7 million who received at least one dose of the vaccine.
About 3.8 million people have been fully vaccinated, according to the Centers for Disease Control and Prevention (CDC).
It comes as the death toll in the United States has risen to 428,654, including 3,990 new deaths. More than 25 million Americans have been diagnosed with COVID-19 since the start of the pandemic.
Encouragingly, cases, deaths and hospitalizations all declined last week compared to previous weeks, but remain high with an average of 3,287 people dying per day.
Dozens of valuable doses of both vaccines were wasted because no one was able to take them before they spoiled, or due to careless mistakes like unplugging freezers.
Johnson & Johnson’s simpler single-dose injection could be of tremendous help in solving some of these problems. It has a contract with the United States for at least a million doses and has committed to distribute a billion doses worldwide this year.
About 20.7 million have received at least one dose of the vaccine. About 3.8 million people have been fully vaccinated, according to the Centers for Disease Control and Prevention (CDC)
Fauci said Johnson & Johnson’s vaccine is being tested on the highly infectious “ super-covid ” variants of South Africa and Brazil.
But even if its results are positive, the FDA is not expected to clear the vaccine for emergency use until March, raising questions about why there must be an agonizing month-long delay.
Meanwhile, Biden has attacked the stakes of his COVID-19 vaccination target, announcing on Monday that he believes the United States could administer more than 1.5 million vaccines per day, up from a million.
Currently, the United States immunizes an average of 1.27 million people per day. Supply could be the biggest obstacle to meeting and sustaining Biden’s goal of vaccinating 1.5 million people per day.
Collectively, Moderna and Pfizer have pledged to deliver 200 million doses by the end of March.
More than 25.5 million infections have been reported in the United States since the start of the pandemic
Pfizer believes it can offer an additional 20 million doses by then, and the United States is in talks with Moderna and Pfizer to purchase another 200 million doses (100 million each), which will be available this summer.
But there is no stock. The federal government is withholding enough supply to cover two to three days of doses in the event of a manufacturing disruption.
Otherwise, he relies on the manufacturers to keep a constant flow of new doses to the state, Slavitt said.
He said the government was “ confident ” in these manufacturers, but even admitted there would likely be disruption in production, and the government is only planning a thin cushion in the midst of a deployment that has so far been chaotic and has left many states on the verge of running out of doses.
[ad_2]
Source link